Skip to search formSkip to main contentSkip to account menu

ditercalinium

Known as: 2,2'-((4,4'-Bipiperidine)-1,1'-Diyldiethylene)Bis(10-Methoxy-7H-Pyrido(4,3-c)Carbazolium) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Covering: 1980 to 2011. Major groove recognition of DNA by proteins utilizes the variation in hydrogen bond donor/acceptor… 
Highly Cited
2002
Highly Cited
2002
The structural selectivity of the DNA‐binding antitumor drug ditercalinium was investigated by competition dialysis with a series… 
Highly Cited
2002
Highly Cited
2002
Atomic force microscopy (AFM) has been used to examine perturbations in the tertiary structure of DNA induced by the binding of… 
1997
1997
Since ethidium bromide was not effective in mouse cell lines for isolating mitochondrial DNA (mtDNA)-less cells (rho zero cells… 
Highly Cited
1993
Highly Cited
1993
In an effort to further extend the number of targets for development of antiretroviral agents, we have used an in vitro integrase… 
Highly Cited
1991
Highly Cited
1991
Ditercalinium is a synthetic anticancer drug that binds to DNA by bis-intercalation and activates DNA repair processes. In… 
1988
1988
Ditercalinium (NSC 335153), a bifunctional intercalating molecule with antitumor activity, is found to express its toxicity… 
1986
1986
Ditercalinium, a 7H-pyridocarbazole dimer (bisintercalator) belongs to a new class of antineoplastic intercalating agents. To…